Give the gift of LIFE! Support the Population Research Institute!

Only $106,679 to go!

Topics: teen health

Dangerous MAP Ads Threaten Public Health



March 26, 2004 Volume 6 / Number 12 Dear Colleague: On February 20, 2004, the Food and Drug Administration (FDA) announced it would delay for 90 days its decision to approve over-the-counter (OTC) status of the morning-after pill (MAP). The FDA said it needed more time to evaluate the use of Plan B among teenagers. The final decision is expected to come on May 20. As the countdown continues, beware of false advertising! “Cutting edge” …

Read more.




‘Emergency Contraception’ and the Dangers to Adolescents



March 5, 2004 Volume 6 / Number 9 Dear Colleague: Last month, the U.S. Food and Drug Administration (FDA) delayed until May its decision on Women’s Capital Corporation’s application for over-the-counter (OTC) status for the morning-after pill, so-called emergency contraception (EC). In order to educate the general public about the abortion-inducing character and other adverse medical consequences of this powerful hormonal drug, PRI, with the help of researcher Julie Wheeland, is publishing an in-depth report. …

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.